Tag: Emergent BioSolutions
Emergent BioSolutions gets $14.5M in federal funding to expedite COVID-19 plasma therapy development
Last week, we spoke to the Head of Emergent BioSolutions’ Therapeutics Business Unit Dr. Laura Saward about her company’s work developing plasma-based potential treatments for COVID-19. Now, the company announced that it has received $14.5 million in funding from the Biomedical Advanced Research and Development Authority (BARDA), which is part…
Read More